Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Anti Inflammatory Drugs Market

Published Date : Jul 2024

Anti-inflammatory drugs are medications that reduce inflammation in the body. These are commonly used to treat joint pain, arthritis, and other conditions associated with inflammation and pain. Some of the major classes of anti-inflammatory drugs include non-steroidal... View more

Coherent Market Insights Immuno Oncology Drugs Market

Published Date : Jul 2024

Immuno-oncology drugs use the body's immune system to fight cancer, and have demonstrated improved survival rates for various cancer types. These drugs boost the immune response against cancer cells, and thus, improve survival outcomes. Some major immuno-oncology drug... View more

Coherent Market Insights Pet Sitting Market

Published Date : Jul 2024

The pet sitting market has seen substantial growth over the past decade. As more individuals now own pets, particularly dogs and cats, and dual income households have become commonplace, there exists a need for pet care services when owners are away. Pet sitting servi... View more

Coherent Market Insights Metastatic Melanoma Therapeutics Market

Published Date : Jul 2024

Metastatic melanoma is a life-threatening form of skin cancer that occurs due to the spread of melanoma skin cancer to other organs of the body. According to recent studies, over 200,000 new cases of melanoma were reported globally in 2020, making it one of the most c... View more

Coherent Market Insights Animal Intestinal Health Market

Published Date : Jul 2024

The global animal intestinal health market has been witnessing significant growth in the recent years. Intestinal health plays a crucial role in overall animal well-being as it helps in the digestion of food and absorption of nutrients. Rising awareness about the impo... View more

Coherent Market Insights Elderly Nutrition Market

Published Date : Jul 2024

Global elderly nutrition market growth is driven by rising geriatric population worldwide and the associated health issues. Nutrition plays a vital role in ensuring the physical well-being and overall health of the aged people. Poor dietary habits and malnutrition amo... View more

Coherent Market Insights Adult Vaccines Market

Published Date : Jul 2024

Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness... View more

Coherent Market Insights Controlled Release Drug Delivery Market

Published Date : Jul 2024

Controlled release delivery mechanism helps in delivering a pharmaceutical active compound or drug over an extended period of time, from hours to days. It offers several advantages over conventional drug delivery such as reduced dosing frequency, better therapeutic ef... View more

Coherent Market Insights Advanced Glycation End Products Market

Published Date : Jul 2024

Global advanced glycation end products market growth is driven by increasing prevalence of diabetes and hypertension coupled with rising geriatric population worldwide. AGEs are molecules formed internally in the body as a result of non-enzymatic reactions between red... View more

Coherent Market Insights Us Complex And Chronic Condition Management Market

Published Date : Jul 2024

Complex chronic conditions refer to multiple chronic conditions occurring simultaneously in a person. These include conditions like diabetes, cancer, arthritis, COPD, Alzheimer's, and others. Factors such as rising geriatric population, increasing incidence of chronic... View more

Coherent Market Insights Critical Limb Ischemia Treatment Market

Published Date : Jul 2024

Global critical limb ischemia treatment market refers to the medical condition where the blood circulation to extremities like legs is severely reduced. This is a serious condition that can lead to amputation if left untreated. The condition arises due to the accumula... View more

Coherent Market Insights Empty Capsules Market

Published Date : Jul 2024

Empty capsules refer to pharmaceutical capsules that do not contain the drug substance but only serve as a vehicle for drug delivery. These are typically made from either gelatin or vegetarian materials like Hypromellose, and are available in different sizes ranging f... View more

Coherent Market Insights Protein A Resin Market

Published Date : Jun 2024

Protein A resin is a medium used for the purification of antibodies through affinity chromatography. Antibodies are the primary targets for affinity chromatography as they have specific regions of interaction with Protein A. Protein A is an Fc-binding bacterial protei... View more

Coherent Market Insights Non Small Cell Lung Cancer Market

Published Date : Jun 2024

Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer that accounts for around 85% of all lung cancers. It is among the leading causes of cancer-related deaths worldwide. Global non-small cell lung cancer market growth is driven by factors like ... View more

Coherent Market Insights Nanotechnology Drug Delivery Market

Published Date : Jun 2024

Nanotechnology-based drug delivery address many challenges in pharmaceutical research and development. By facilitating targeted and controlled delivery of therapeutic agents, nanotechnology improves  the solubility, stability and bioavailability of drug payloads.... View more

Coherent Market Insights Nephrology Drugs Market

Published Date : Jun 2024

Global nephrology drugs market has been witnessing robust growth due to rising prevalence of kidney diseases around the world. Kidney or renal diseases have emerged as a major public health issue, disproportionately affecting the elderly population. According to the U... View more

Coherent Market Insights First Aid Kit Market

Published Date : Jun 2024

Global first aid kit market is witnessing growth due to rising instances of accidents and injuries across industrial, commercial, and residential settings. First aid kits are essential medical supplies that provide initial aid and management of wounds until profession... View more

Coherent Market Insights Proton Pump Inhibitors Market

Published Date : Jun 2024

Proton pump inhibitors (PPIs) are a group of medicines that work by reducing the amount of acid produced in the stomach. PPIs are commonly used to treat acid reflux, ulcers, and inflammation of the esophagus. These work by blocking the action of the proton pump, an en... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.